Changes to Labeling Aim to Stop Use of Benzodiazepines and Opioids at the Same Time
The FDA recently announced class-wide changes to the way benzodiazepine and opioid medications are labeled in an effort to stop doctors from prescribing both types of drugs together inappropriately. When this happens, there is an increased risk for depression of the central nervous system and death.
